Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality glasses tested to calm ICU patients without drugs

NCT ID NCT07013877

Symptom relief Sponsor: Centre Hospitalier de Valenciennes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using RELAX glasses—a device that plays calming videos and sounds—can lower anxiety in ICU patients during invasive procedures like getting an IV or a catheter. About 456 adults in intensive care will either use the glasses or receive standard care. Their anxiety levels will be measured before and after the procedure to see if the glasses help.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RELAX glasses (audiovisual distraction device)
What this could lead to
If it works, this could offer a drug-free way to ease anxiety during stressful ICU procedures, potentially improving patient recovery and reducing medication side effects.
What could go wrong
This is an early-stage trial with no phase, and the effect may be small or not generalizable. The glasses might not reduce anxiety more than usual care, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 456 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients hospitalized in intensive care, post-operative intensive care and continuous monitoring; * Patient receiving invasive care placement of peripheral venous line, nasogastric tube insertion, bladder catheterization, dressing stage IV pressure sores, heavy dressing lasting \> 15 minutes arterial gasometry by puncture; * Patient of legal age; * Patient with written consent; * Patient with Glasgow score equal to 15; * Socially insured patient; * Patient willing to comply with all study procedures and duration. Exclusion Criteria: * Medical history contraindicating RELAX eyewear; * Known and current abuse of alcohol and/or illicit drugs that may interfere with patient safety and/or compliance; * Any condition that would make the patient unsuitable for the study: current presence of cognitive disorders (MMS \< 15), severe psychiatric disorders (bipolar disorders, psychotic disorders according to DSM-V classification); * Major anxiety requiring anxiolytic medication prior to invasive care; * Patient under court protection; * Patient participating in another study; * Patient who has already participated in the DARE study. * Patient's refusal to use glasses; * Visually impaired or blind patient.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.